-+ 0.00%
-+ 0.00%
-+ 0.00%

Septerna to present preclinical data on oral hypoparathyroidism drug SEP-479 at ENDO 2026

PUBT·06/08/2026 12:55:56
Listen to the news
Septerna to present preclinical data on oral hypoparathyroidism drug SEP-479 at ENDO 2026
  • Septerna will present preclinical data on SEP-479 at the Endocrine Society’s ENDO 2026 meeting in Chicago on June 13-16, 2026.
  • The oral presentation is scheduled for June 13, 2026, 2:15-2:30 p.m. CT.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Septerna Inc. published the original content used to generate this news brief on June 08, 2026, and is solely responsible for the information contained therein.